Antibiotics, Antineoplastic
"Antibiotics, Antineoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
Below are MeSH descriptors whose meaning is more general than "Antibiotics, Antineoplastic".
Below are MeSH descriptors whose meaning is more specific than "Antibiotics, Antineoplastic".
This graph shows the total number of publications written about "Antibiotics, Antineoplastic" by people in Harvard Catalyst Profiles by year, and whether "Antibiotics, Antineoplastic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 0 | 3 |
1995 | 4 | 1 | 5 |
1996 | 9 | 3 | 12 |
1997 | 4 | 9 | 13 |
1998 | 9 | 5 | 14 |
1999 | 7 | 2 | 9 |
2000 | 6 | 4 | 10 |
2001 | 7 | 8 | 15 |
2002 | 6 | 8 | 14 |
2003 | 8 | 5 | 13 |
2004 | 13 | 5 | 18 |
2005 | 5 | 11 | 16 |
2006 | 8 | 9 | 17 |
2007 | 7 | 4 | 11 |
2008 | 6 | 9 | 15 |
2009 | 7 | 15 | 22 |
2010 | 6 | 8 | 14 |
2011 | 13 | 8 | 21 |
2012 | 14 | 13 | 27 |
2013 | 11 | 6 | 17 |
2014 | 11 | 7 | 18 |
2015 | 10 | 7 | 17 |
2016 | 9 | 10 | 19 |
2017 | 6 | 8 | 14 |
2018 | 6 | 5 | 11 |
2019 | 12 | 5 | 17 |
2020 | 6 | 4 | 10 |
2021 | 4 | 3 | 7 |
2022 | 0 | 7 | 7 |
2023 | 1 | 5 | 6 |
Below are the most recent publications written about "Antibiotics, Antineoplastic" by people in Profiles.
-
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial. JAMA. 2023 08 08; 330(6):528-536.
-
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia. Leuk Res. 2023 09; 132:107351.
-
Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis. Curr Probl Cardiol. 2023 Oct; 48(10):101885.
-
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. Eur J Cancer. 2023 08; 189:112935.
-
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023 03; 24(3):e108-e120.
-
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 04 20; 41(12):2248-2257.
-
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice. Sci Adv. 2022 12 23; 8(51):eadc9245.
-
Quatramerâ„¢ mediated co-delivery of PI3-Kd/HDAC6 dual inhibitor augments the anti-cancer efficacy of Epirubicin in breast cancer. Eur J Pharm Biopharm. 2022 Oct; 179:184-193.
-
Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review. Acta Oncol. 2022 Sep; 61(9):1093-1104.
-
Statin Therapy for Prevention of Anthracycline Cardiotoxicity - Another Defeat for Cardioprotection? NEJM Evid. 2022 Sep; 1(9):EVIDe2200166.